Microarray expression profile and analysis of circular RNA regulatory network in malignant pleural effusion

References

• Penz E, Watt KN, Hergott CA, et al. Management of malignant pleural effusion: challenges and solutions. Cancer Manag Res. 2017;9:229–241.
   PubMed Web of Science ®Google Scholar
• Sugiura S, Ando Y, Minami H, et al. Prognostic value of pleural effusion in patients with non-small cell lung cancer. Clin Cancer Res. 1997;3(1):47–50.
   PubMed Web of Science ®Google Scholar
• Goldstraw P, Crowley J, Chansky K, et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007;2(8):706–714.
   PubMed Web of Science ®Google Scholar
• Roberts ME, Neville E, Berrisford RG, et al. Management of a malignant pleural effusion: british thoracic society pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii32–40.
   PubMed Web of Science ®Google Scholar
• Antony VB, Loddenkemper R, Astoul P, et al. Management of malignant pleural effusions. Eur Respir J. 2001;18(2):402–419.
   PubMed Web of Science ®Google Scholar
• Psallidas I, Kalomenidis I, Porcel JM, et al. Malignant pleural effusion: from bench to bedside. Eur Respir Rev. 2016;25(140):189–198.
   PubMed Web of Science ®Google Scholar
• Hooper C, Lee YC, Maskell N. Investigation of a unilateral pleural effusion in adults: british thoracic society pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii4–17.
   PubMed Web of Science ®Google Scholar
• Zhu S, Xia L, Yu S, et al. The burden and challenges of tuberculosis in China: findings from the global burden of disease study 2015. Sci Rep. 2017;7(1):14601.
   PubMedGoogle Scholar
• Stathopoulos GT, Kalomenidis I. Malignant pleural effusion: tumor-host interactions unleashed. Am J Respir Crit Care Med. 2012;186(6):487–492.
   PubMed Web of Science ®Google Scholar
• Chen YQ, Shi HZ, Qin XJ, et al. CD4+CD25+ regulatory T lymphocytes in malignant pleural effusion. Am J Respir Crit Care Med. 2005;172(11):1434–1439.
   PubMed Web of Science ®Google Scholar
• Ye ZJ, Zhou Q, Gu YY, et al. Generation and differentiation of IL-17-producing CD4+ T cells in malignant pleural effusion. J Immunol. 2010;185(10):6348–6354.
   PubMed Web of Science ®Google Scholar
• Ye ZJ, Zhou Q, Yin W, et al. Interleukin 22-producing CD4+ T cells in malignant pleural effusion. Cancer Lett. 2012;326(1):23–32.
   PubMed Web of Science ®Google Scholar
• Ye ZJ, Zhou Q, Yin W, et al. Differentiation and immune regulation of IL-9- producing CD4+ T cells in malignant pleural effusion. Am J Respir Crit Care Med. 2012;186(11):1168–1179.
   PubMed Web of Science ®Google Scholar
• Lin H, Tong ZH, Xu QQ, et al. Interplay of Th1 and Th17 cells in murine models of malignant pleural effusion. Am J Respir Crit Care Med. 2014;189(6):697–706.
   PubMed Web of Science ®Google Scholar
• Han HS, Yun J, Lim SN, et al. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion. Int J Cancer. 2013;133(3):645–652.
   PubMed Web of Science ®Google Scholar
• Shin YM, Yun J, Lee OJ, et al. Diagnostic value of circulating extracellular miR-134, miR-185, and miR-22 levels in lung adenocarcinoma-associated malignant pleural effusion. Cancer Res Treat. 2014;46(2):178–185.
   PubMed Web of Science ®Google Scholar
• Xie L, Wang T, Yu S, et al. Cell-free miR-24 and miR-30d, potential diagnostic biomarkers in malignant effusions. Clin Biochem. 2011;44(2–3):216–220.
   PubMed Web of Science ®Google Scholar
• Xie L, Chen X, Wang L, et al. Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions. BMC Cancer. 2010;10:591.
   PubMed Web of Science ®Google Scholar
• Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. Rna. 2013;19(2):141–157.
   PubMed Web of Science ®Google Scholar
• Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333–338.
   PubMed Web of Science ®Google Scholar
• Salzman J, Chen RE, Olsen MN, et al. Cell-type specific features of circular RNA expression. PLoS Genet. 2013;9(9):e1003777.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Zuo Y, Wang J, et al. Characterization of RNase R-digested cellular RNA source that consists of lariat and circular RNAs from pre-mRNA splicing. Nucleic Acids Res. 2006;34(8):e63.
   PubMed Web of Science ®Google Scholar
• Hsiao KY, Sun HS, Tsai SJ, et al. New member of noncoding RNA with novel functions. Exp Biol Med (Maywood). 2017;242(11):1136–1141.
   PubMed Web of Science ®Google Scholar
• Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32(5):453–461.
   PubMed Web of Science ®Google Scholar
• Hsiao KY, Lin YC, Gupta SK, et al. Noncoding effects of circular RNA CCDC66 promote colon cancer growth and metastasis. Cancer Res. 2017;77(9):2339–2350.
   PubMed Web of Science ®Google Scholar
• Chen J, Li Y, Zheng Q, et al. Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer. Cancer Lett. 2017;388:208–219.
   PubMed Web of Science ®Google Scholar
• Li H, Hao X, Wang H, et al. Circular RNA expression profile of pancreatic ductal adenocarcinoma revealed by microarray. Cell Physiol Biochem. 2016;40(6):1334–1344.
   PubMed Web of Science ®Google Scholar
• Xuan L, Qu L, Zhou H, et al. Circular RNA: a novel biomarker for progressive laryngeal cancer. Am J Transl Res. 2016;8(2):932–939.
   PubMed Web of Science ®Google Scholar
• Pasquinelli AE. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet. 2012;13(4):271–282.
   PubMed Web of Science ®Google Scholar
• Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120(1):15–20.
   PubMed Web of Science ®Google Scholar
• Wong N, Wang X. miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. 2015;43(Databaseissue):D146–152.
   PubMed Web of Science ®Google Scholar
• Light RW, Macgregor MI, Luchsinger PC, et al. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med. 1972;77(4):507–513.
   PubMed Web of Science ®Google Scholar
• Yang JH, Qu LH. DeepBase: annotation and discovery of microRNAs and other noncoding RNAs from deep-sequencing data. Methods Mol Biol. 2012;822:233–248.
   PubMedGoogle Scholar
• Wang T, Lv M, Shen S, et al. Cell-free microRNA expression profiles in malignant effusion associated with patient survival in non-small cell lung cancer. PloS one. 2012;7(8):e43268.
   PubMed Web of Science ®Google Scholar
• Jiang G, Ma Y, An T, et al. Relationships of circular RNA with diabetes and depression. Sci Rep. 2017;7(1):7285.
   PubMedGoogle Scholar
• Ouyang Q, Wu J, Jiang Z, et al. Microarray expression profile of circular RNAs in peripheral blood mononuclear cells from rheumatoid arthritis patients. Cell Physiol Biochem. 2017;42(2):651–659.
   PubMed Web of Science ®Google Scholar
• Cui X, Niu W, Kong L, et al. hsa_circRNA_103636: potential novel diagnostic and therapeutic biomarker in major depressive disorder. Biomark Med. 2016;10(9):943–952.
   PubMed Web of Science ®Google Scholar
• Wu N, Jin L, Cai J. Profiling and bioinformatics analyses reveal differential circular RNA expression in hypertensive patients. Clin Exp Hypertens. 2017;39(5):454–459.
   PubMed Web of Science ®Google Scholar
• Zhong L, Wang Y, Cheng Y, et al. Circular RNA circC3P1 suppresses hepatocellular carcinoma growth and metastasis through miR-4641/PCK1 pathway. Biochem Biophys Res Commun. 2018;499(4):1044–1049.
   PubMed Web of Science ®Google Scholar
• Zeng K, Chen X, Xu M, et al. CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7. Cell Death Dis. 2018;9(4):417.
   PubMed Web of Science ®Google Scholar
• Ma X, Yang X, Bao W, et al. Circular RNA circMAN2B2 facilitates lung cancer cell proliferation and invasion via miR-1275/FOXK1 axis. Biochem Biophys Res Commun. 2018;498(4):1009–1015.
   PubMed Web of Science ®Google Scholar
• Bao L, Hazari S, Mehra S, et al. Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298. Am J Pathol. 2012;180(6):2490–2503.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Wang S, Zhu J, et al. MicroRNA-544 down-regulates both Bcl6 and Stat3 to inhibit tumor growth of human triple negative breast cancer. Biol Chem. 2016;397(10):1087–1095.
   PubMed Web of Science ®Google Scholar
• Slattery ML, Mullany LE, Sakoda LC, et al. The PI3K/AKT signaling pathway: associations of miRNAs with dysregulated gene expression in colorectal cancer. Mol Carcinog. 2018;57(2):243–261.
   PubMed Web of Science ®Google Scholar
• Kanlikilicer P, Rashed MH, Bayraktar R, et al. Ubiquitous release of exosomal tumor suppressor miR-6126 from ovarian cancer cells. Cancer Res. 2016;76(24):7194–7207.
   PubMed Web of Science ®Google Scholar
• Chu J, Li Y, Fan X, et al. MiR-4319 suppress the malignancy of triple-negative breast cancer by regulating self-renewal and tumorigenesis of stem cells. Cell Physiol Biochem. 2018;48(2):593–604.
   PubMed Web of Science ®Google Scholar
• Li S, Zhang H, Ning T, et al. MiR-520b/e regulates proliferation and migration by simultaneously targeting EGFR in gastric cancer. Cell Physiol Biochem. 2016;40(6):1303–1315.
   PubMed Web of Science ®Google Scholar
• Wei S, Zhang ZY, Fu SL, et al. Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma. Cell Death Dis. 2016;7(9):e2388.
   PubMedGoogle Scholar
• Osaki M, Oshimura M, Ito H. PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis. 2004;9(6):667–676.
   PubMed Web of Science ®Google Scholar
• Sousa-Squiavinato ACM, Rocha MR, Barcellos-de-Souza P, et al. Cofilin-1 signaling mediates epithelial-mesenchymal transition by promoting actin cytoskeleton reorganization and cell-cell adhesion regulation in colorectal cancer cells. Biochim Biophys Acta Mol Cell Res. 2018;pii: S0167–4889(18)30429–4.
   PubMed Web of Science ®Google Scholar
• Okada T, Sinha S, Esposito I, et al. The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling. Nat Cell Biol. 2015;17(1):81–94.
   PubMed Web of Science ®Google Scholar